Sivik Global Healthcare’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100,000
Closed -$2.71M 56
2020
Q4
$2.71M Sell
100,000
-25,000
-20% -$643K 1.1% 36
2020
Q3
$3.14M Sell
125,000
-173,700
-58% -$2.53M 1.35% 36
2020
Q2
$2.28M Buy
+298,700
New +$2.19M 0.75% 45
2016
Q2
Sell
-50,000
Closed -$2.02M 63
2016
Q1
$2.02M Sell
50,000
-10,000
-17% -$372K 0.89% 44
2015
Q4
$2.16M Buy
60,000
+28,199
+89% +$1.02M 1.03% 44
2015
Q3
$1.02M Sell
31,801
-48,199
-60% -$1.64M 0.49% 54
2015
Q2
$2.72M Sell
80,000
-400
-0.5% -$13.5K 0.94% 43
2015
Q1
$2.72M Buy
80,400
+30,500
+61% +$1.06M 0.93% 49
2014
Q4
$1.75M Sell
49,900
-50,100
-50% -$1.69M 0.71% 59
2014
Q3
$3.27M Buy
100,000
+33,100
+49% +$1.13M 1.49% 32
2014
Q2
$2.27M Sell
66,900
-2,040
-3% -$69.9K 1.15% 40
2014
Q1
$2.42M Buy
+68,940
New +$2.43M 1.51% 29

Other funds holding ACH

Sivik Global Healthcare's ACH Position: Q1 2021 in Review

Sivik Global Healthcare sold out of Accendra Health (ACH) in Q1 2021, closing a stake of 100,000 shares — an estimated $2.71M sold.

Sivik Global Healthcare first reported a position in ACH in Q1 2014 and held it in 12 quarters. The position peaked at $3.27M in Q3 2014. 253 funds tracked by Wall St. Rank hold ACH as of Q1 2021.

  • Sivik Global Healthcare reported no remaining Accendra Health position as of Q1 2021 after selling out during the quarter.
  • Sivik Global Healthcare sold 100,000 Accendra Health shares in Q1 2021, an estimated $2.71M.
  • Sivik Global Healthcare first reported a position in Accendra Health in Q1 2014 and held it in 12 quarters.
  • Sivik Global Healthcare's Accendra Health position peaked at $3.27M in Q3 2014.
  • 253 funds tracked by Wall St. Rank held Accendra Health as of Q1 2021.

Based on Sivik Global Healthcare's 13F filing for Q1 2021, filed 12 May 2021.